Evidence map›Paper›PMID 31259073›Full record

ArticleBiomedical optics express2019

Supervised learning to quantify amyloidosis in whole brains of an Alzheimer's disease mouse model acquired with optical projection tomography.

David Nguyen, Virginie Uhlmann, Arielle L Planchette, Paul J Marchand, Dimitri Van De Ville, Theo Lasser, Aleksandra Radenovic

Open access · goldAbstract read
In one paragraph

Article in Biomedical optics express, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

David NguyenLaboratory of Nanoscale Biology, École Polytechnique Fédérale de Lausanne, Lausanne, Vaud, Switzerland.
Virginie UhlmannBiomedical Imaging Group, École Polytechnique Fédérale de Lausanne, Lausanne, Vaud, Switzerland.
Arielle L PlanchetteLaboratory of Nanoscale Biology, École Polytechnique Fédérale de Lausanne, Lausanne, Vaud, Switzerland.
Paul J MarchandLaboratoire d'Optique Biomédicale, École Polytechnique Fédérale de Lausanne, Lausanne, Vaud, Switzerland.
Dimitri Van De VilleMedical Image Processing Lab, École Polytechnique Fédérale de Lausanne, Genève, Genève, Switzerland.
Theo LasserLaboratoire d'Optique Biomédicale, École Polytechnique Fédérale de Lausanne, Lausanne, Vaud, Switzerland.
Aleksandra RadenovicLaboratory of Nanoscale Biology, École Polytechnique Fédérale de Lausanne, Lausanne, Vaud, Switzerland.
École Polytechnique Fédérale de Lausanne · CHEuropean Bioinformatics Institute · GBUniversity of Geneva · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Alzheimer's disease (AD) is characterized by amyloidosis of brain tissues. This phenomenon is studied with genetically-modified mouse models. We propose a method to quantify amyloidosis in whole 5xFAD mouse brains, a model of AD. We use optical projection tomography (OPT) and a random forest voxel classifier to segment and measure amyloid plaques. We validate our method in a preliminary cross-sectional study, where we measure 6136 ± 1637, 8477 ± 3438, and 17267 ± 4241 plaques (AVG ± SD) at 11, 17, and 31 weeks. Overall, this method can be used in the evaluation of new treatments against AD.

Identifiers

PMID31259073
PMCPMC6583328
OpenAlexW2947569849

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.